EORTC 10941: a phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer

A Hamilton; J-A Roy; L Beex; M Piccart; L Mauriac; R Coleman; R Paridaens; G Hoctin Boes; A van Vreckem; P Palmer; Jan Klijn

doi:10.1023/A:1006398518037

EORTC 10941: a phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer

A Hamilton, J-A Roy, L Beex, M Piccart, L Mauriac, R Coleman, R Paridaens, G Hoctin Boes, A van Vreckem, P Palmer, Jan Klijn

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	181-188
Number of pages	8
Journal	Breast Cancer Research and Treatment
Volume	60
DOIs	https://doi.org/10.1023/A:1006398518037
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1023/A:1006398518037

http://hdl.handle.net/1765/70275

Cite this

Hamilton, A., Roy, J-A., Beex, L., Piccart, M., Mauriac, L., Coleman, R., Paridaens, R., Hoctin Boes, G., van Vreckem, A., Palmer, P., & Klijn, J. (2000). EORTC 10941: a phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer. Breast Cancer Research and Treatment, 60, 181-188. https://doi.org/10.1023/A:1006398518037

@article{f25c2936f2094a7aba647fca64ddf8f9,

title = "EORTC 10941: a phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer",

author = "A Hamilton and J-A Roy and L Beex and M Piccart and L Mauriac and R Coleman and R Paridaens and {Hoctin Boes}, G and {van Vreckem}, A and P Palmer and Jan Klijn",

year = "2000",

doi = "10.1023/A:1006398518037",

language = "Undefined/Unknown",

volume = "60",

pages = "181--188",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

}

Hamilton, A, Roy, J-A, Beex, L, Piccart, M, Mauriac, L, Coleman, R, Paridaens, R, Hoctin Boes, G, van Vreckem, A, Palmer, P & Klijn, J 2000, 'EORTC 10941: a phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer', Breast Cancer Research and Treatment, vol. 60, pp. 181-188. https://doi.org/10.1023/A:1006398518037

TY - JOUR

T1 - EORTC 10941: a phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer

AU - Hamilton, A

AU - Roy, J-A

AU - Beex, L

AU - Piccart, M

AU - Mauriac, L

AU - Coleman, R

AU - Paridaens, R

AU - Hoctin Boes, G

AU - van Vreckem, A

AU - Palmer, P

AU - Klijn, Jan

PY - 2000

Y1 - 2000

U2 - 10.1023/A:1006398518037

DO - 10.1023/A:1006398518037

M3 - Article

SN - 0167-6806

VL - 60

SP - 181

EP - 188

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

ER -